Growth Hormone

CJC-1295

Mechanism

A synthetic growth-hormone-releasing hormone (GHRH) analogue. Two variants: with DAC (Drug Affinity Complex), half-life ~8 days; without DAC, half-life ~30 minutes. Stimulates pituitary GH release, raising IGF-1 and supporting recovery, body composition, and sleep.

Typical dose

100-300mcg per injection, 1-3 times per week (with DAC) or daily (no-DAC).

Cycle length

8-12 weeks on, 4 weeks off

Form

Injectable (subcutaneous)

Deep dives on CJC-1295

Ipamorelin Complete Guide: The Cleanest GH Secretagogue and Why It Earned That Reputation (2026)Ipamorelin is the cleanest GH secretagogue available for research, releasing GH without cortisol elevation. Evidence-based guide covering mechanism, dosing, safety
CJC-1295 Side Effects and Safety: Water Retention, Numbness, Glucose, and What to Watch (2026)CJC-1295 side effects include water retention, tingling, and glucose changes. This guide covers mechanisms, dose-risk correlations, monitoring protocols, and what to
Why CJC/Ipamorelin Will Dominate Peptide Prescriptions in 2026CJC ipamorelin will dominate 2026 peptide prescriptions after April's FDA Category 1 reclassification. Here's the mechanism, clinical data, and prescribing guide.
CJC-1295 Dosage Protocol: DAC vs No-DAC, Loading, and Maintenance (2026 Guide)CJC-1295 dosage guide covering DAC vs no-DAC pharmacokinetics, loading protocols, maintenance dosing, cycling, and the clinical evidence behind every number.
CJC-1295 + Ipamorelin Stack Protocol: The Gold Standard GH Combination (2026)The gold standard label for CJC-1295 + ipamorelin oversells thin human data. We examine when this stack underperforms and what the evidence actually shows.

Get the Pre-Protocol Checklist

Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.